Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2019

01-12-2019 | Gastric Cancer | ASO Author Reflections

ASO Author Reflections: The Prognostic Role of Exosomal PD-L1 in Patients with Gastric Cancer

Authors: Yibo Fan, MD, PhD, Yunpeng Liu, MD, PhD, Xiujuan Qu, MD, PhD

Published in: Annals of Surgical Oncology | Special Issue 3/2019

Login to get access

Excerpt

The role of tumor PD-L1 expression in the prognosis of GC still remained to be controversial.1,2 Except tumor membrane PD-L1, extracellular soluble and exosomal forms of PD-L1 also existed in the tumor microenvironment.3,4 Previous studies have almost focused on the role of soluble PD-L1 in cancer patients. However, exosome secreted by tumors plays an important role in regulating tumor immune escape. Exosomal PD-L1 might not only inhibit and kill T cells in local tumor microenvironment and even exert its function in the distant area, leading tumor immune escape. However, it is unknown whether gastric cancer cells could secrete exosomal PD-L1, what is the potential effect in gastric cancer patients, and the difference between exosomal PD-L1 and sPD-L1. …
Literature
1.
go back to reference Eto S, Yoshikawa K, Nishi M, et al. Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection. Gastric Cancer. 2016; 19(2):466–71.CrossRef Eto S, Yoshikawa K, Nishi M, et al. Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection. Gastric Cancer. 2016; 19(2):466–71.CrossRef
2.
go back to reference Kim JW, Nam KH, Ahn SH, et al. Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer. Gastric Cancer. 2016; 19(1): 42–52.CrossRef Kim JW, Nam KH, Ahn SH, et al. Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer. Gastric Cancer. 2016; 19(1): 42–52.CrossRef
3.
go back to reference Frigola X, Inman BA, Lohse CM, et al. Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma. Clin Cancer Res. 2011; 17(7): 1915–23.CrossRef Frigola X, Inman BA, Lohse CM, et al. Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma. Clin Cancer Res. 2011; 17(7): 1915–23.CrossRef
4.
go back to reference Theodoraki MN, Yerneni SS, Hoffmann TK, et al. Clinical significance of PD-L1 + exosomes in plasma of head and neck cancer patients. Clin Cancer Res. 2018; 24(4):896–905.CrossRef Theodoraki MN, Yerneni SS, Hoffmann TK, et al. Clinical significance of PD-L1 + exosomes in plasma of head and neck cancer patients. Clin Cancer Res. 2018; 24(4):896–905.CrossRef
6.
go back to reference Chen G, Huang AC, Zhang W, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018; 560(7718):382–86.CrossRef Chen G, Huang AC, Zhang W, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018; 560(7718):382–86.CrossRef
Metadata
Title
ASO Author Reflections: The Prognostic Role of Exosomal PD-L1 in Patients with Gastric Cancer
Authors
Yibo Fan, MD, PhD
Yunpeng Liu, MD, PhD
Xiujuan Qu, MD, PhD
Publication date
01-12-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07864-0

Other articles of this Special Issue 3/2019

Annals of Surgical Oncology 3/2019 Go to the issue